Table 1 Clinical characteristics of patients with HCC in train and test group.
Characteristics | Train (N = 182) | Test (N = 183) | Total (N = 365) | pvalue | FDR |
|---|---|---|---|---|---|
Age | |||||
Mean ± SD | 58.71 ± 14.01 | 60.57 ± 12.65 | 59.65 ± 13.36 | ||
Median[min–max] | 61.00 [16.00,90.00] | 61.00 [17.00,85.00] | 61.00 [16.00,90.00] | ||
Gender | 1 | 1 | |||
Female | 59 (16.16%) | 60 (16.44%) | 119 (32.60%) | ||
Male | 123 (33.70%) | 123 (33.70%) | 246 (67.40%) | ||
AJCC stage | 0.69 | 1 | |||
I | 90 (24.66%) | 80 (21.92%) | 170 (46.58%) | ||
II | 41 (11.23%) | 43 (11.78%) | 84 (23.01%) | ||
III | 36 (9.86%) | 47 (12.88%) | 83 (22.74%) | ||
IV | 2 (0.55%) | 2 (0.55%) | 4 (1.10%) | ||
NA | 13 (3.56%) | 11 (3.01%) | 24 (6.58%) | ||
Grade | 0.97 | 1 | |||
G1 | 28 (7.67%) | 27 (7.40%) | 55 (15.07%) | ||
G2 | 89 (24.38%) | 86 (23.56%) | 175 (47.95%) | ||
G3 | 56 (15.34%) | 62 (16.99%) | 118 (32.33%) | ||
G4 | 6 (1.64%) | 6 (1.64%) | 12 (3.29%) | ||
NA | 3 (0.82%) | 2 (0.55%) | 5 (1.37%) | ||
